1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Vaxcyte, Inc.
  6. Calendar
    PCVX   US92243G1085

VAXCYTE, INC.

(PCVX)
  Report
Delayed Nasdaq  -  05/17 04:00:00 pm EDT
25.27 USD   +2.97%
05/10TRANSCRIPT : Vaxcyte, Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-2022 02:40 PM
CI
05/09VAXCYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/09Vaxcyte Reports First Quarter 2022 Financial Results and Provides Business Update
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart VAXCYTE, INC.
Upcoming events on VAXCYTE, INC.
05/23/22 UBS Global Healthcare Conference
06/01/22 Annual General Meeting
08/17/22 Interim 2022 Earnings Release (Projected)
11/17/22 Q3 2022 Earnings Release (Projected)
03/27/23 FY 2022 Earnings Release (Projected)
Past events on VAXCYTE, INC.
05/10/22 | 05:40pm Bank of America Healthcare Conference
05/10/22 Q1 2022 Earnings Release (Projected)
04/12/22 | 12:45pm Needham Virtual Healthcare Conference
02/28/22 | 04:30pm FY 2021 Earnings Call
02/28/22 | 04:10pm FY 2021 Earnings Release
02/18/22 | 02:20pm SVB Leerink Global Healthcare Conference
12/01/21 | 04:45pm Evercore ISI HealthCONx Conference
11/22/21 | 10:00am Piper Sandler Virtual Healthcare Conference
11/18/21 | 03:00am Jefferies London Healthcare Conference
11/10/21 | 04:10pm Q3 2021 Earnings Release
Past dividends on VAXCYTE, INC.

- No events available -

Annual results
Fiscal Period : December2019202020212022
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 
-88,2
-89,8
1,8%
-102
-98,0
-3,9%
 
-123
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread


 
-89,6
-95,8
6,5%
-104
-103
-0,85%
 
-166
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 
-89,2
-95,5
6,6%
-100
-101
1,0%
 
-166
 
Net income
M $
Released
Forecast
Spread
-50,3

 
-89,2
-93,4
4,5%
-100
-100
0,04%
 
-166
 
EPS
$
Released
Forecast
Spread
-13,2

 
-3,02
-2,81
-7,5%
-1,93
-1,89
-2,3%
 
-2,83
 
Announcement Date05/22/202003/29/202102/28/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread


 


 


 


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-23,1
-29,7
22%
-23,7
-28,3
16%
-27,0
-29,4
8,2%
-29,8
-30,3
1,4%
-39,2
-35,8
-9,6%
 
-40,6
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-21,2
-28,9
26%
-23,7
-26,9
12%
-26,6
-28,7
7,2%
-28,6
-29,7
3,7%
-39,0
-35,5
-9,9%
 
-40,5
 
Net income
M $
Released
Forecast
Spread
-21,2
-28,9
26%
-23,7
-26,9
12%
-26,6
-28,7
7,2%
-28,6
-29,7
3,7%
-39,0
-35,5
-9,9%
 
-40,5
 
EPS
$
Released
Forecast
Spread
-0,41
-0,51
20%
-0,46
-0,52
12%
-0,51
-0,55
6,7%
-0,54
-0,55
1,2%
-0,68
-0,63
-8,5%
 
-0,69
 
Announcement Date05/11/202108/11/202111/10/202102/28/202205/09/2022-
Previous year Next Year
Upcoming sector events for VAXCYTE, INC.
More events
Past sector events for VAXCYTE, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise